603538.SHG Ningbo Menovo Pharm Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
21.48 CNY
Close of Nov 4, 2026
13.55 50.28
Market cap
CNY 7.30B
P/E
59.7x
P/B
2.29x
ROE
4.7%
Dividend yield
0.35%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603538.SHG undervalued?

Graham number
Price21.48
Graham value8.72
Premium146.4%

603538.SHG trades 146.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Ningbo Menovo Pharm Co Ltd fundamental analysis

No fundamental analysis for Ningbo Menovo Pharm Co Ltd yet.

Ningbo Menovo Pharm Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Ningbo Menovo Pharm Co Ltd

Ningbo Menovo Pharmaceutical Co., Ltd. research, develops, produces, and sells pharmaceutical products. The company's products portfolio includes valsartan, losartan, clopidogrel, perindopril, rosuvastatin ca, atorvastatin ca, pregabalin, and other products. It offers APIs, intermediates, and preparations for the treatment of cardiovascular, central nervous, gastrointestinal and digestive tracts, and other therapeutic areas. The company was founded in 2004 and is headquarter…

Full company profile